Skip to main content

Primary Effusion Lymphoma

  • Reference work entry
  • First Online:
Encyclopedia of AIDS
  • 52 Accesses

Definition

Primary effusion lymphoma (PEL) is a rare non-Hodgkin’s lymphoma that characteristically presents as a malignant effusion in the body cavities of patients with AIDS and occasionally in other patients with an underlying immunodeficiency. The malignant PEL cells are infected with Kaposi’s sarcoma-associated herpesvirus (KSHV, also known as human herpesvirus-8, HHV8) and are often coinfected with Epstein-Barr virus (EBV). PEL cells display morphologic features of large-cell lymphomas and are of B-cell lineage. The diagnosis of PEL is characteristically made in AIDS patients presenting with a malignant effusion in the pleural, pericardial, or peritoneal cavity characterized by the presence of KSHV-infected cells with characteristic morphology and phenotype. The clinical course of PEL is generally aggressive, with a mean survival of less than 1 year, despite chemotherapy.

Introduction

PEL was recognized as a distinct clinical entity when it was discovered that certain...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • An J, Sun Y, Fisher M, Rettig MB. Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia. 2004;18:1699–704.

    Article  CAS  PubMed  Google Scholar 

  • Aoki Y, Feldman GM, Tosato G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood. 2003;101:1535–42.

    Article  CAS  PubMed  Google Scholar 

  • Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in primary effusion lymphoma by Kaposi’s sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 2007;26:4979–86.

    Article  CAS  PubMed  Google Scholar 

  • Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186–91.

    Article  CAS  PubMed  Google Scholar 

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–9.

    Article  CAS  PubMed  Google Scholar 

  • Gasperini P, Tosato G. Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia. 2009;23:1867–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guasparri I, Keller SA, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med. 2004;199:993–1003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi’s sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999;94:2871–9.

    CAS  PubMed  Google Scholar 

  • Luppi M, Trovato R, Barozzi P, Vallisa D, Rossi G, Re A, et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia. 2005;19:473–6.

    Article  CAS  PubMed  Google Scholar 

  • Menon MP, Pittaluga S, Jaffe ES. The histological and biological spectrum of diffuse large B-cell lymphoma in the world health organization classification. Cancer J. 2012;18:411–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L. How I treat HHV8/KSHV-related diseases in post-transplant patients. Blood. 2012;11.

    Google Scholar 

  • Sakakibara S, Tosato G. Viral interleukin-6: role in Kaposi’s sarcoma-associated herpesvirus: associated malignancies. J Interferon Cytokine Res. 2011;31:791–801.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sarek G, Ma L, Enback J, Jarviluoma A, Moreau P, Haas J, et al. Kaposi’s sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas. Oncogene. 2012;2.

    Google Scholar 

  • Speck SH, Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe. 2010;8:100–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yarchoan R, Tosato G, Little RF. Therapy insight: AIDS-related malignancies–the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol. 2005;2:406–15.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanna Tosato .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Tosato, G. (2018). Primary Effusion Lymphoma. In: Hope, T.J., Richman, D.D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7101-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7101-5_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7100-8

  • Online ISBN: 978-1-4939-7101-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics